{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:12:26Z","timestamp":1778649146791,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.htct.2025.103861","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:58:17Z","timestamp":1750049897000},"page":"103861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD36 as a marker of acute myeloid leukemia prognosis: A systematic review"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-5507","authenticated-orcid":false,"given":"Marina Chaves","family":"Amant\u00e9a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5089-7046","authenticated-orcid":false,"given":"Rafaela Pires","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1325-1086","authenticated-orcid":false,"given":"Larissa Ranini","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8299-9373","authenticated-orcid":false,"given":"Jo\u00e3o Lorenzo de Medeiros","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-5068","authenticated-orcid":false,"given":"Ana Paula Duarte","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.htct.2025.103861_bib0001","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12098-015-1695-5","article-title":"Leukemias in children","volume":"82","author":"Seth","year":"2015","journal-title":"Ind J Pediatr"},{"issue":"9","key":"10.1016\/j.htct.2025.103861_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18369","article-title":"Recent advances in CAR-T cell therapy for acute myeloid leukaemia","volume":"28","author":"Gao","year":"2024","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.htct.2025.103861_bib0003","article-title":"Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing","volume":"14","author":"Zhou","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.htct.2025.103861_bib0004","series-title":"SEER Cancer Statistics Review, 1975-2018 [Internet]","year":"2021"},{"issue":"3","key":"10.1016\/j.htct.2025.103861_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2014.11.017","article-title":"Targeting novel signaling pathways for resistant acute myeloid leukemia","volume":"114","author":"Sakamoto","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.htct.2025.103861_bib0006","first-page":"83","article-title":"Childhood and adolescent cancer statistics, 2014","volume":"64","author":"Ward","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.htct.2025.103861_bib0007","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00277-019-03661-7","article-title":"Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country","volume":"98","author":"Lins","year":"2019","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.htct.2025.103861_bib0008","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajh.25484","article-title":"Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia","volume":"94","author":"Medeiros","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0009","first-page":"17","article-title":"Clinical significance of cytogenetics in acute myeloid leukemia","volume":"24","author":"Mr\u00f3zek","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.htct.2025.103861_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-2-23","article-title":"Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics","volume":"2","author":"Gregory","year":"2009","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.htct.2025.103861_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1329529","article-title":"Global, national, and regional burden of acute myeloid leukemia among 60-89\u2009years-old individuals: insights from a study covering the period 1990 to 2019","volume":"11","author":"Chen","year":"2024","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cyto.b.21539","article-title":"The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia","volume":"94","author":"van Solinge","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.htct.2025.103861_bib0013","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34+CD38\u2212 leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2019","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.htct.2025.103861_bib0014","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00277-020-03907-9","article-title":"Identification of CD318 (CDCP1) as novel prognostic marker in AML","volume":"99","author":"Heitmann","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2025.103861_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodr\u00edguez","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.htct.2025.103861_bib0016","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant Human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.htct.2025.103861_bib0017","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.4049\/jimmunol.1502033","article-title":"CD nomenclature 2015: human leukocyte differentiation antigen workshops as a driving force in immunology","volume":"195","author":"Engel","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2404015","article-title":"Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]","volume":"20","author":"Perea","year":"2006","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.htct.2025.103861_bib0019","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00432-022-03957-8","article-title":"CD36: an emerging therapeutic target for cancer and its molecular mechanisms","volume":"148","author":"Ruan","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7635","key":"10.1016\/j.htct.2025.103861_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.htct.2025.103861_bib0021","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","article-title":"Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis","volume":"37","author":"Ladanyi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.htct.2025.103861_bib0022","unstructured":"The role of CD36 in the prognosis of acute myeloid leukemia: a systematic review. PROSPERO; 2023; CRD42023481493. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023481493."},{"key":"10.1016\/j.htct.2025.103861_bib0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030266","article-title":"Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"10","author":"Shamsrizi","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.htct.2025.103861_bib0025","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood.V79.9.2415.2415","article-title":"Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance","volume":"79","author":"Smith","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.103861_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106603","article-title":"Lymphoid markers predict prognosis of pediatric and adolescent acute myeloid leukemia","volume":"107","author":"Hoch","year":"2021","journal-title":"Leuk Res"},{"issue":"16","key":"10.1016\/j.htct.2025.103861_bib0027","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.7150\/jca.50502","article-title":"Prognostic and immunological role of CD36: a pan-cancer analysis","volume":"12","author":"Chen","year":"2021","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113112","article-title":"IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia","volume":"415","author":"Zhang","year":"2022","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7123\/01.EJH.0000423008.85761.a3","article-title":"Clinical relevance of thrombospondin receptor (CD36) expression in Egyptian de novo adult acute myeloid leukemia","volume":"38","author":"El-Aziz","year":"2013","journal-title":"Egypt. J. Haematol."},{"issue":"10","key":"10.1016\/j.htct.2025.103861_bib0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.leukres.2005.02.015","article-title":"Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients","volume":"29","author":"Perea","year":"2005","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cyto.b.10028","article-title":"Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters","volume":"53","author":"Valet","year":"2003","journal-title":"Cytometry B Clin Cytom"},{"issue":"17","key":"10.1016\/j.htct.2025.103861_bib0032","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1158\/0008-5472.CAN-22-3682","article-title":"CD36 Drives metastasis and relapse in acute myeloid leukemia","volume":"83","author":"Farge","year":"2023","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.htct.2025.103861_bib0033","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/2643-3230.BCD-19-0077","article-title":"Apolipoprotein C2 - CD36 promotes leukemia growth and presents a targetable axis in acute myeloid leukemia","volume":"1","author":"Zhang","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"17","key":"10.1016\/j.htct.2025.103861_bib0034","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.7150\/thno.36037","article-title":"CD36 tango in cancer: signaling pathways and functions","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.htct.2025.103861_bib0035","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells12121605","article-title":"The role of CD36 in cancer progression and its value as a therapeutic target","volume":"12","author":"Feng","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.htct.2025.103861_bib0036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:23:32Z","timestamp":1754580212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2531137925001294"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.103861","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD36 as a marker of acute myeloid leukemia prognosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.103861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103861"}}